期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
New advances of adiponectin in regulating obesity and related metabolic syndromes
1
作者 Yanqi Han Qianwen Sun +7 位作者 Wei chen Yue Gao Jun Ye yanmin chen Tingting Wang Lili Gao Yuling Liu Yanfang Yang 《Journal of Pharmaceutical Analysis》 SCIE CAS CSCD 2024年第5期623-638,共16页
Obesity and related metabolic syndromes have been recognized as important disease risks,in which the role of adipokines cannot be ignored.Adiponectin(ADP)is one of the key adipokines with various beneficial effects,in... Obesity and related metabolic syndromes have been recognized as important disease risks,in which the role of adipokines cannot be ignored.Adiponectin(ADP)is one of the key adipokines with various beneficial effects,including improving glucose and lipid metabolism,enhancing insulin sensitivity,reducing oxidative stress and inflammation,promoting ceramides degradation,and stimulating adipose tissue vascularity.Based on those,it can serve as a positive regulator in many metabolic syndromes,such as type 2 diabetes(T2D),cardiovascular diseases,non-alcoholic fatty liver disease(NAFLD),sarcopenia,neurodegenerative diseases,and certain cancers.Therefore,a promising therapeutic approach for treating various metabolic diseases may involve elevating ADP levels or activating ADP receptors.The modulation of ADP genes,multimerization,and secretion covers the main processes of ADP generation,providing a comprehensive orientation for the development of more appropriate therapeutic strategies.In order to have a deeper understanding of ADP,this paper will provide an all-encompassing review of ADP. 展开更多
关键词 ADIPONECTIN OBESITY Metabolic syndrome REGULATION
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部